BR112014015101A8 - métodos para intensificar eficiência de etapas de cromatografia a jusante para purificação de anticorpos - Google Patents
métodos para intensificar eficiência de etapas de cromatografia a jusante para purificação de anticorposInfo
- Publication number
- BR112014015101A8 BR112014015101A8 BR112014015101A BR112014015101A BR112014015101A8 BR 112014015101 A8 BR112014015101 A8 BR 112014015101A8 BR 112014015101 A BR112014015101 A BR 112014015101A BR 112014015101 A BR112014015101 A BR 112014015101A BR 112014015101 A8 BR112014015101 A8 BR 112014015101A8
- Authority
- BR
- Brazil
- Prior art keywords
- polypeptide
- membrane
- interest
- effluent
- ion exchange
- Prior art date
Links
- 238000011210 chromatographic step Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 238000011091 antibody purification Methods 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 9
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 9
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 9
- 239000012528 membrane Substances 0.000 abstract 5
- 239000000356 contaminant Substances 0.000 abstract 3
- 239000003014 ion exchange membrane Substances 0.000 abstract 3
- 238000000746 purification Methods 0.000 abstract 2
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 238000004255 ion exchange chromatography Methods 0.000 abstract 1
- 150000002500 ions Chemical class 0.000 abstract 1
- 238000001742 protein purification Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
Abstract
métodos para intensificar eficiência de etapas de cromatografia a jusante para purificação de anticorpos. a presente invenção refere-se a métodos para intensificar eficiência de etapas de cromatografia a jusante para purificação de proteínas que compreende: (a) passar uma composição compreendendo um polipeptídeo de interesse e vários contaminantes através de uma membrana de troca iônica, em que o polipeptídeo e a membrana têm cargas opostas, em condições de operação compreendidas de um tampão tendo um ph suficientemente distinto do pi do polipeptídeo para intensificar a carga do polipeptídeo e uma intensidade iônica baixa eficaz para evitar a blindagem das cargas por íons de tampão, o que faz a membrana ligar o polipeptídeo e pelo menos um contaminante; (b) sobrecarregar a membrana de troca iônica, de modo que pelo menos um contaminante permaneça ligado à membrana enquanto o polipeptídeo de interesse está primariamente no efluente; (c) coletar o efluente da membrana de troca iônica compreendendo o poli peptídeo de interesse; (d) submeter o efluente de membrana compreendendo o polipeptídeo de interesse a uma etapa de purificação de carga similar à membrana anterior, e (e) recuperar o polipeptídeo purificado do efluente da etapa de purificação de cromatografia de troca iônica carregada.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161579285P | 2011-12-22 | 2011-12-22 | |
| PCT/US2012/070373 WO2013096322A1 (en) | 2011-12-22 | 2012-12-18 | Ion exchange membrane chromatography |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112014015101A2 BR112014015101A2 (pt) | 2017-06-13 |
| BR112014015101A8 true BR112014015101A8 (pt) | 2021-06-08 |
Family
ID=47430154
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014015101A BR112014015101A8 (pt) | 2011-12-22 | 2012-12-18 | métodos para intensificar eficiência de etapas de cromatografia a jusante para purificação de anticorpos |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US10364268B2 (pt) |
| EP (2) | EP2794635B8 (pt) |
| JP (5) | JP6605202B2 (pt) |
| KR (3) | KR102067075B1 (pt) |
| CN (2) | CN108892706A (pt) |
| AR (1) | AR089362A1 (pt) |
| AU (3) | AU2012355356B2 (pt) |
| BR (1) | BR112014015101A8 (pt) |
| CA (1) | CA2859376C (pt) |
| ES (1) | ES2697676T3 (pt) |
| HK (1) | HK1203526A1 (pt) |
| HR (1) | HRP20181846T1 (pt) |
| IL (2) | IL267585B (pt) |
| MX (2) | MX360453B (pt) |
| MY (1) | MY172426A (pt) |
| PL (1) | PL2794635T3 (pt) |
| RU (1) | RU2648999C2 (pt) |
| SG (1) | SG11201403437TA (pt) |
| SI (1) | SI2794635T1 (pt) |
| TR (1) | TR201815709T4 (pt) |
| WO (1) | WO2013096322A1 (pt) |
| ZA (2) | ZA201404593B (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012355356B2 (en) * | 2011-12-22 | 2017-10-12 | Genentech, Inc. | Ion exchange membrane chromatography |
| SG10201804200WA (en) | 2013-12-12 | 2018-07-30 | Emd Millipore Corp | Protein separations using an acrylamide containing filter |
| JP6722455B2 (ja) | 2013-12-27 | 2020-07-15 | 中外製薬株式会社 | 等電点の低い抗体の精製方法 |
| CN104693303B (zh) * | 2015-02-28 | 2018-03-13 | 苏州金盟生物技术有限公司 | 一种蛋白制品中的核酸去除方法 |
| ES2964640T3 (es) | 2015-08-13 | 2024-04-08 | Amgen Inc | Filtración en profundidad cargada de proteínas de unión al antígeno |
| GB201711481D0 (en) | 2017-07-17 | 2017-08-30 | Ucb Biopharma Sprl | Protein purification |
| EP3546475A1 (en) * | 2018-03-27 | 2019-10-02 | Sanofi | Full flow-through process for purifying recombinant proteins |
| US10792618B2 (en) | 2018-06-19 | 2020-10-06 | Sartorius Stedim Biotech Gmbh | Particle separation and/or purification of a fluid |
| GB201815405D0 (en) * | 2018-09-21 | 2018-11-07 | Fujifilm Mfg Europe Bv | Membranes suitable for detecting, filtering and/or purifying biomolecules |
| WO2020128797A1 (en) * | 2018-12-21 | 2020-06-25 | 3M Innovative Properties Company | Method for testing a chromatography device used for ion exchange |
| AR119264A1 (es) * | 2019-06-05 | 2021-12-09 | Genentech Inc | Método para reutilización de cromatografía |
| US11416468B2 (en) * | 2020-07-21 | 2022-08-16 | International Business Machines Corporation | Active-active system index management |
| CN116371011B (zh) * | 2023-05-26 | 2023-08-18 | 湖南杰萃生物技术有限公司 | 一种从桑叶中提取黄酮和生物碱的方法 |
Family Cites Families (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE266710C (pt) | ||||
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
| US4515893A (en) | 1979-04-26 | 1985-05-07 | Ortho Pharmaceutical Corporation | Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
| US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| JPS6150925A (ja) * | 1984-08-17 | 1986-03-13 | Toray Ind Inc | 抗原または抗体の精製方法 |
| US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
| GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
| US5091178A (en) | 1986-02-21 | 1992-02-25 | Oncogen | Tumor therapy with biologically active anti-tumor antibodies |
| US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
| GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| AU626008B2 (en) * | 1987-10-23 | 1992-07-23 | Schering Corporation | Method of purifying protein |
| US5091313A (en) | 1988-08-05 | 1992-02-25 | Tanox Biosystems, Inc. | Antigenic epitopes of IgE present on B cell but not basophil surface |
| US5720937A (en) | 1988-01-12 | 1998-02-24 | Genentech, Inc. | In vivo tumor detection assay |
| DE68919361T2 (de) | 1988-06-21 | 1995-05-24 | Genentech Inc | Therapeutische zusammensetzungen für die behandlung von myocard-infarkten. |
| EP0435911B1 (en) | 1988-09-23 | 1996-03-13 | Cetus Oncology Corporation | Cell culture medium for enhanced cell growth, culture longevity and product expression |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| JP2844346B2 (ja) * | 1989-05-31 | 1999-01-06 | 昭 梶 | 新規ペプチドならびに新規ｄｎａ |
| EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| DE122006000006I2 (de) | 1991-08-14 | 2011-06-16 | Genentech Inc | Veränderte Immunglobuline für spezifische FC-Epsilon Rezeptoren |
| DE69233528T2 (de) | 1991-11-25 | 2006-03-16 | Enzon, Inc. | Verfahren zur Herstellung von multivalenten antigenbindenden Proteinen |
| CA2372813A1 (en) | 1992-02-06 | 1993-08-19 | L.L. Houston | Biosynthetic binding protein for cancer marker |
| EP0656789B1 (en) | 1992-08-21 | 1997-12-17 | Genentech, Inc. | Method for treating a lfa-1-mediated disorder |
| US5736137A (en) | 1992-11-13 | 1998-04-07 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| US5595721A (en) | 1993-09-16 | 1997-01-21 | Coulter Pharmaceutical, Inc. | Radioimmunotherapy of lymphoma using anti-CD20 |
| RU2145873C1 (ru) * | 1993-09-21 | 2000-02-27 | Хемосол Инк. | Способ очистки гемоглобина в коммерческом масштабе |
| US5714338A (en) | 1993-12-10 | 1998-02-03 | Genentech, Inc. | Methods for diagnosis of allergy |
| AP660A (en) | 1994-01-18 | 1998-08-18 | Genentech Inc | A method of treatment of parasitic infection using IgE antagonists. |
| US5677426A (en) | 1994-03-03 | 1997-10-14 | Genentech, Inc. | Anti-IL-8 antibody fragments |
| US5534615A (en) | 1994-04-25 | 1996-07-09 | Genentech, Inc. | Cardiac hypertrophy factor and uses therefor |
| IL117645A (en) | 1995-03-30 | 2005-08-31 | Genentech Inc | Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration |
| US5641870A (en) * | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| EP0831880A4 (en) | 1995-06-07 | 2004-12-01 | Imclone Systems Inc | ANTIBODIES AND FRAGMENTS OF ANTIBODIES INHIBITING TUMOR GROWTH |
| EP1297847A3 (en) | 1996-01-23 | 2003-05-07 | Genentech, Inc. | Anti-CD18 antibodies in stroke |
| AU1458497A (en) * | 1996-01-31 | 1997-08-22 | John Stephen Ayers | Production of an immunoglobulin enriched fraction from whey protein solutions |
| US7147851B1 (en) | 1996-08-15 | 2006-12-12 | Millennium Pharmaceuticals, Inc. | Humanized immunoglobulin reactive with α4β7 integrin |
| DK1516629T3 (da) | 1996-11-27 | 2013-06-03 | Genentech Inc | Humaniseret anti-CD-11a antibodies |
| AU743758B2 (en) | 1997-04-07 | 2002-02-07 | Genentech Inc. | Anti-VEGF antibodies |
| CA2287911C (en) | 1997-05-15 | 2014-05-06 | Genentech, Inc. | Apo-2 receptor |
| US6054293A (en) | 1997-07-08 | 2000-04-25 | The Regents Of The University Of California | Semaphorin receptors |
| US6946129B1 (en) | 1999-06-08 | 2005-09-20 | Seattle Genetics, Inc. | Recombinant anti-CD40 antibody and uses thereof |
| CN101518653B (zh) | 1999-06-25 | 2015-08-19 | 基因技术股份有限公司 | 使用抗ErbB抗体-类美坦素偶联物的治疗方法 |
| DE60039448D1 (de) | 1999-10-29 | 2008-08-21 | Genentech Inc | Gegen das prostata-stammzellantigen (psca) gerichtete antikörper und deren verwendung |
| CA2415713A1 (en) * | 2000-07-13 | 2002-01-24 | Invitrogen Corporation | Methods and compositions for rapid protein and peptide extraction and isolation using a lysis matrix |
| UA83458C2 (uk) | 2000-09-18 | 2008-07-25 | Байоджен Айдек Ма Інк. | Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf) |
| US7321026B2 (en) | 2001-06-27 | 2008-01-22 | Skytech Technology Limited | Framework-patched immunoglobulins |
| WO2003025156A2 (en) | 2001-09-18 | 2003-03-27 | Affinium Pharmaceuticals, Inc. | Methods and apparatuses for purification |
| AU2002332130A1 (en) | 2001-10-16 | 2003-04-28 | Exelixis, Inc. | Msrebps as modifiers of the srebp pathway and methods of use |
| EP1507793A4 (en) | 2001-10-17 | 2006-02-01 | Human Genome Sciences Inc | NEUTROKIN ALPHA AND NEUTROKIN ALPHA SPLICE VERSION |
| US20040093621A1 (en) | 2001-12-25 | 2004-05-13 | Kyowa Hakko Kogyo Co., Ltd | Antibody composition which specifically binds to CD20 |
| KR101033196B1 (ko) | 2002-02-14 | 2011-05-09 | 이뮤노메딕스, 인코오포레이티드 | 항-ｃｄ20 항체 및 그 융합 단백질 및 이들의 이용방법 |
| PL216630B1 (pl) | 2002-10-17 | 2014-04-30 | Genmab As | Izolowane ludzkie przeciwciało monoklonalne wiążące ludzki CD20, związane z tym przeciwciałem transfektoma, komórka gospodarza, transgeniczne zwierzę lub roślina, kompozycja, immunokoniugat, cząsteczka bispecyficzna, wektor ekspresyjny, kompozycja farmaceutyczna, zastosowanie medyczne, zestaw oraz przeciwciało antyidiotypowe i jego zastosowanie |
| ES2347241T3 (es) | 2002-12-16 | 2010-10-27 | Genentech, Inc. | Variantes de inmunoglobulina y sus utilizaciones. |
| CN1206240C (zh) * | 2003-04-07 | 2005-06-15 | 中国科学院生态环境研究中心 | 高效离子交换膜色谱纯化卵黄蛋白原技术 |
| KR101351122B1 (ko) | 2003-05-09 | 2014-01-14 | 듀크 유니버시티 | Ｃｄ２０-특이적 항체 및 이를 이용한 방법 |
| AR044388A1 (es) | 2003-05-20 | 2005-09-07 | Applied Molecular Evolution | Moleculas de union a cd20 |
| WO2005014618A2 (en) | 2003-08-08 | 2005-02-17 | Immunomedics, Inc. | Bispecific antibodies for inducing apoptosis of tumor and diseased cells |
| US8147832B2 (en) | 2003-08-14 | 2012-04-03 | Merck Patent Gmbh | CD20-binding polypeptide compositions and methods |
| US20080274501A1 (en) * | 2007-05-02 | 2008-11-06 | Chenming Zhang | Method of purifying acidic proteins expressed in plants |
| US9433922B2 (en) | 2007-08-14 | 2016-09-06 | Emd Millipore Corporation | Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same |
| EP2719705B1 (en) | 2007-10-26 | 2020-07-29 | Asahi Kasei Kabushiki Kaisha | Method for purifying protein |
| KR20140015166A (ko) | 2007-10-30 | 2014-02-06 | 제넨테크, 인크. | 양이온 교환 크로마토그래피에 의한 항체 정제 |
| WO2009135656A1 (en) * | 2008-05-06 | 2009-11-12 | Lonza Biologics Plc. | A method for the purification of antibodies using displacement chromatography |
| ES2749190T3 (es) | 2008-08-14 | 2020-03-19 | Genentech Inc | Métodos para eliminar un contaminante usando cromatografía de membrana de intercambio iónico de desplazamiento de proteínas indígenas |
| GB0816242D0 (en) | 2008-09-05 | 2008-10-15 | Immunobiology Ltd | Method of purifying protien complexes |
| EP2462158B1 (en) | 2009-08-06 | 2018-01-10 | F. Hoffmann-La Roche AG | Method to improve virus removal in protein purification |
| ES2787234T3 (es) | 2009-09-01 | 2020-10-15 | Hoffmann La Roche | Purificación de proteínas potenciada a través de una elución de proteína A modificada |
| CA2796633C (en) * | 2010-04-23 | 2020-10-27 | Genentech, Inc. | Production of heteromultimeric proteins |
| WO2011150110A1 (en) * | 2010-05-25 | 2011-12-01 | Genentech, Inc. | Methods of purifying polypeptides |
| CN103958016B (zh) * | 2011-10-03 | 2015-12-23 | 塞克姆公司 | 用于疏水性置换色谱法的中性两性离子置换剂分子 |
| AU2012355356B2 (en) | 2011-12-22 | 2017-10-12 | Genentech, Inc. | Ion exchange membrane chromatography |
| WO2015198451A1 (ja) | 2014-06-26 | 2015-12-30 | 楽天株式会社 | 情報処理装置、情報処理方法及び情報処理プログラム |
-
2012
- 2012-12-18 AU AU2012355356A patent/AU2012355356B2/en active Active
- 2012-12-18 CN CN201810818291.3A patent/CN108892706A/zh active Pending
- 2012-12-18 TR TR2018/15709T patent/TR201815709T4/tr unknown
- 2012-12-18 WO PCT/US2012/070373 patent/WO2013096322A1/en active Application Filing
- 2012-12-18 RU RU2014130017A patent/RU2648999C2/ru active
- 2012-12-18 PL PL12806322T patent/PL2794635T3/pl unknown
- 2012-12-18 SI SI201231443T patent/SI2794635T1/sl unknown
- 2012-12-18 KR KR1020147019968A patent/KR102067075B1/ko active IP Right Grant
- 2012-12-18 MX MX2014007622A patent/MX360453B/es active IP Right Grant
- 2012-12-18 MY MYPI2014701665A patent/MY172426A/en unknown
- 2012-12-18 KR KR1020217005616A patent/KR20210025692A/ko not_active Application Discontinuation
- 2012-12-18 CN CN201280070369.9A patent/CN104125963B/zh active Active
- 2012-12-18 US US14/365,449 patent/US10364268B2/en active Active
- 2012-12-18 KR KR1020207000846A patent/KR20200008022A/ko not_active IP Right Cessation
- 2012-12-18 EP EP12806322.9A patent/EP2794635B8/en active Active
- 2012-12-18 ES ES12806322T patent/ES2697676T3/es active Active
- 2012-12-18 SG SG11201403437TA patent/SG11201403437TA/en unknown
- 2012-12-18 JP JP2014549204A patent/JP6605202B2/ja active Active
- 2012-12-18 EP EP18193475.3A patent/EP3492486A1/en active Pending
- 2012-12-18 IL IL267585A patent/IL267585B/en unknown
- 2012-12-18 BR BR112014015101A patent/BR112014015101A8/pt not_active Application Discontinuation
- 2012-12-18 CA CA2859376A patent/CA2859376C/en active Active
- 2012-12-20 AR ARP120104862A patent/AR089362A1/es not_active Application Discontinuation
-
2014
- 2014-06-16 IL IL233158A patent/IL233158B/en active IP Right Grant
- 2014-06-20 MX MX2018013356A patent/MX2018013356A/es unknown
- 2014-06-23 ZA ZA2014/04593A patent/ZA201404593B/en unknown
-
2015
- 2015-04-27 HK HK15104046.9A patent/HK1203526A1/xx unknown
-
2018
- 2018-01-10 AU AU2018200194A patent/AU2018200194B2/en active Active
- 2018-02-13 JP JP2018023128A patent/JP2018109024A/ja not_active Withdrawn
- 2018-11-05 HR HRP20181846TT patent/HRP20181846T1/hr unknown
-
2019
- 2019-06-06 US US16/433,763 patent/US11945837B2/en active Active
- 2019-06-20 ZA ZA2019/03994A patent/ZA201903994B/en unknown
- 2019-10-24 JP JP2019193276A patent/JP7402011B2/ja active Active
-
2020
- 2020-02-14 AU AU2020201070A patent/AU2020201070A1/en not_active Abandoned
-
2021
- 2021-06-22 JP JP2021102974A patent/JP7359807B2/ja active Active
-
2022
- 2022-03-25 JP JP2022050501A patent/JP2022101557A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014015101A8 (pt) | métodos para intensificar eficiência de etapas de cromatografia a jusante para purificação de anticorpos | |
| CY1122221T1 (el) | Μεθοδοι αφαιρεσης ρυπου χρησιμοποιωντας ιοντοανταλλακτικη μεμβρανικη χρωματογραφια μετατοπισης γηγενων πρωτεϊνων | |
| BR112012017124A2 (pt) | método de modificação polipeptídica para purificação de multímeros polipeptídicos | |
| BRPI0611600B8 (pt) | método para purificação de uma proteína tendo uma região fc a partir de um líquido fonte compreendendo a proteína e uma ou mais impurezas, e kit | |
| BR112015031196A2 (pt) | “processo de purificação de anticorpo monoclonal” | |
| RU2011137030A (ru) | Способы очистки малых модулярных иммунофармацевтических белков | |
| BR112017018365A2 (pt) | uso de lavagens alcalinas durante cromatografia para remoção de impurezas | |
| BR112012004697A2 (pt) | purificação melhorada de proteína através de uma eluição da proteína a modificada. | |
| HRP20150639T1 (hr) | Postupak za proäśišä†avanje proteina | |
| BR112015014751A2 (pt) | anticorpos anti-tau humanos | |
| MA40510A (fr) | Molécules bispécifiques de liaison à l'antigène activant les lymphocytes t | |
| BR112012009289B8 (pt) | método para purificar um anticorpo anti-il-13 a partir de uma mistura de amostra que compreende um anticorpo anti-il-13 e pelo menos uma proteína de célula hospedeira (hcp) | |
| JOP20180117B1 (ar) | أجسام مضادة انتقائية لـ tau فائق المعالجة بفوسفوريلات وطرق لاستخدامها | |
| EA200701452A1 (ru) | Моноклональные антитела против подобного ангиопоэтину белка 4 (angptl 4) | |
| EA201101593A1 (ru) | КОМПОЗИЦИИ И СПОСОБЫ, ПРЕДНАЗНАЧЕННЫЕ ДЛЯ НАПРАВЛЕННОГО ВОЗДЕЙСТВИЯ АНТИТЕЛ НА БЕЛОК С3b СИСТЕМЫ КОМПЛЕМЕНТА | |
| BR112012014937A2 (pt) | solução de lavagem e método para cromatografia de afinidade | |
| RU2014111820A (ru) | Способы элиминации вируса | |
| BR112013019508A2 (pt) | purificação de insulina | |
| BR112013000623A2 (pt) | purificação de proteína. | |
| RU2014147741A (ru) | Модифицированные области антител и их применение | |
| BR112017010069A2 (pt) | redução seletiva de resíduos cisteína em anticorpos para il-17 | |
| BR112012024956A2 (pt) | processo para a purificação de uma proteína de fator de crescimento | |
| BR112018001511A2 (pt) | ?uso de solução aquosa com baixa condutividade e métodos de produção e purificação de anticorpo de isótipo igg1 ou igg4 humano | |
| BR112019024602A2 (pt) | ensaio para doença associada à célula de plasma | |
| EA201990593A1 (ru) | Непрерывный способ для снижения гетерогенности терапевтического белка |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS. |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO EM FUNCAO DA REVOGACAO DO ART. 229-C DA LEI NO 9.279, DE 1996, POR FORCA DA LEI NO 14.195, DE 2021 |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] |